A new type of antibiotic pill may treat drug-resistant gonorrhea. It could be available this year.
The pill, called gepotidacin, was approved by the Food and Drug Administration in March to treat uncomplicated urinary tract infections in women and girls 12 and up — the most common type of infection in women. The drug is sold under the name Blujepa.
A new treatment option is important, experts say, because bacteria that commonly cause STIs are increasingly becoming resistant to the standard antibiotics, making treatment more difficult.
There are an estimated 82 million new cases of gonorrhea globally each year, according to GSK. In the United States, rates of reported gonorrhea have increased 118% from 2009 to 2021, with more than 640,000 cases being reported to the Centers for Disease Control and Prevention in 2022.
Gonorrhea has developed resistance to nearly all the antibiotics used for its treatment, according to the CDC.
If left untreated, gonorrhea can lead to serious health complications, including swollen and painful joints, liver inflammation, and heart and brain damage. It can also increase the risk of infertility in women.
Gepotidacin is part of a new class of antibiotics called triazaacenaphthylenes, which work by targeting two key enzymes that gonorrhea needs to copy itself and survive.
In a Phase 3 clinical trial of more than 600 adults and teens, gepotidacin was shown to successfully treat about 92% of patients when taken twice daily, compared with about 91% in a group of patients who got a standard treatment.
The most common side effect was gastrointestinal issues, with almost all reported being 'mild or moderate.'
Crucially, the study authors wrote, the pill was effective against strains of gonorrhea bacteria that are resistant to existing antibiotics.
Dr. Sovrin Shah, an associate professor of urology at Mount Sinai Hospital in New York who was not involved in the study, called the GSK pill 'a welcome addition.'
'Antibiotic-resistant gonorrhea is a public health concern,' Shah said. 'The rate of STIs is significant in the U.S.'
David Harvey, executive director of the National Coalition of STD Directors, said 'we desperately need effective cures to combat gonorrhea,' but noted that widespread job cuts at the federal health agencies, including to a lab that tracked STIs, could make it challenging.
'The recent closure of the CDC's key STI lab — which helps us understand which antibiotics are still effective and when we need to engage new drugs like this — poses a significant new obstacle,' Harvey said.
A spokesperson for GSK said the company plans to file approval with the FDA 'in the coming months' with a regulatory decision expected in the second half of the year.
The company said it's seeking approval for gepotidacin as an alternative to first-line therapy when such treatment is inappropriate — such as when the patient is intolerant to the existing treatment or unwilling to use it.
In an editorial that accompanied the study, Magnus Unemo, director of the World Health Organization's division that oversees gonorrhea, said GSK's pill is 'promising,' but added that challenges to keep gonorrhea as a treatable infection will continue.
Unemo also stressed improved prevention, including the promotion of safe sex and condom use, early diagnosis and surveillance.
This article was originally published on NBCNews.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
AMA and other medical associations are kicked out of CDC vaccine workgroups
NEW YORK (AP) — U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations. The government told the organizations on Thursday via email that their experts are being disinvited from the workgroups that have been the backbone of the Advisory Committee on Immunization Practices. The organizations include the American Medical Association, the American Academy of Pediatrics and the Infectious Diseases Society of America. 'I'm concerned and distressed,' said Dr. William Schaffner, a Vanderbilt University vaccine expert who for decades has been involved with ACIP and its workgroups. He said the move will likely propel a confusing fragmentation of vaccine guidance, as patients may hear the government say one thing and hear their doctors say another. One email said the organizations are 'special interest groups and therefore are expected to have a 'bias' based on their constituency and/or population that they represent.' A federal health official on Friday confirmed the action, which was first reported by Bloomberg. The decision was the latest development in what has become a saga involving the ACIP. The committee, created in 1964, makes recommendations to the Centers for Disease Control and Prevention on how vaccines that have been approved by the Food and Drug Administration should be used. CDC directors have traditionally almost always approved those recommendations, which are widely heeded by doctors and greenlight insurance coverage for shots. U.S. Health Secretary Robert F. Kennedy Jr. was a leading voice in the anti-vaccine movement before becoming the U.S. government's top health official, and in June abruptly fired the entire ACIP after accusing them of being too closely aligned with manufacturers. He handpicked replacements that include several vaccine skeptics. The workgroups typically include committee members and experts from medical and scientific organizations. At workgroup meetings, members evaluate data from vaccine manufacturers and the CDC, and formulate vaccination recommendation proposals to be presented to the full committee. The structure was created for several reasons, Schaffner said. The professional groups provide input about what might and might not be possible for doctors to implement. And it helped build respect and trust in ACIP recommendations, having the buy-in of respected medical organizations, he said. Workgroup members are vetted for conflicts of interest, to make sure than no one who had, say, made money from working on a hepatitis vaccine was placed on the hepatitis committee, Schaffner noted. Also disinvited from the groups were the American Academy of Family Physicians, the American College of Physicians, the American Geriatrics Society, the American Osteopathic Association, the National Medical Association and the National Foundation for Infectious Diseases. In a joint statement Friday, the AMA and several of the other organizations said: 'To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines.' They urged the administration to reconsider the move "so we can continue to feel confident in its vaccine recommendations for our patients.' Some of the professional organizations have criticized Kennedy's changes to the ACIP, and three of the disinvited groups last month joined a lawsuit against the government over Kennedy's decision to stop recommending COVID-19 vaccines for most children and pregnant women. In a social media post Friday, one of the Kennedy-appointed ACIP members — Retsef Levi — wrote that the working groups 'will engage experts from even broader set of disciplines!' Levi, a business management professor, also wrote that working group membership 'will be based on merit & expertise — not membership in organizations proven to have (conflicts of interest) and radical & narrow view of public health!' HHS officials have not said which people are going to be added to the ACIP workgroups. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Mike Stobbe, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
an hour ago
- Wall Street Journal
Trump Administration Blocks Funding for CDC Health Programs
WASHINGTON—The Trump administration is blocking funding for a swath of public-health programs run by the Centers for Disease Control and Prevention, the latest flashpoint in a push by the White House to withhold money already approved by Congress. The White House Office of Management and Budget issued the directions in a footnote on an appropriations memo this past week, according to people familiar with the matter. A range of programs won't be fully funded under the freeze.
Associated Press
an hour ago
- Associated Press
AMA and other medical associations are kicked out of CDC vaccine workgroups
NEW YORK (AP) — U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations. The government told the organizations on Thursday via email that their experts are being disinvited from the workgroups that have been the backbone of the Advisory Committee on Immunization Practices. The organizations include the American Medical Association, the American Academy of Pediatrics and the Infectious Diseases Society of America. 'I'm concerned and distressed,' said Dr. William Schaffner, a Vanderbilt University vaccine expert who for decades has been involved with ACIP and its workgroups. He said the move will likely propel a confusing fragmentation of vaccine guidance, as patients may hear the government say one thing and hear their doctors say another. One email said the organizations are 'special interest groups and therefore are expected to have a 'bias' based on their constituency and/or population that they represent.' A federal health official on Friday confirmed the action, which was first reported by Bloomberg. The decision was the latest development in what has become a saga involving the ACIP. The committee, created in 1964, makes recommendations to the Centers for Disease Control and Prevention on how vaccines that have been approved by the Food and Drug Administration should be used. CDC directors have traditionally almost always approved those recommendations, which are widely heeded by doctors and greenlight insurance coverage for shots. U.S. Health Secretary Robert F. Kennedy Jr. was a leading voice in the anti-vaccine movement before becoming the U.S. government's top health official, and in June abruptly fired the entire ACIP after accusing them of being too closely aligned with manufacturers. He handpicked replacements that include several vaccine skeptics. The workgroups typically include committee members and experts from medical and scientific organizations. At workgroup meetings, members evaluate data from vaccine manufacturers and the CDC, and formulate vaccination recommendation proposals to be presented to the full committee. The structure was created for several reasons, Schaffner said. The professional groups provide input about what might and might not be possible for doctors to implement. And it helped build respect and trust in ACIP recommendations, having the buy-in of respected medical organizations, he said. Workgroup members are vetted for conflicts of interest, to make sure than no one who had, say, made money from working on a hepatitis vaccine was placed on the hepatitis committee, Schaffner noted. Also disinvited from the groups were the American Academy of Family Physicians, the American College of Physicians, the American Geriatrics Society, the American Osteopathic Association, the National Medical Association and the National Foundation for Infectious Diseases. In a joint statement Friday, the AMA and several of the other organizations said: 'To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines.' They urged the administration to reconsider the move 'so we can continue to feel confident in its vaccine recommendations for our patients.' Some of the professional organizations have criticized Kennedy's changes to the ACIP, and three of the disinvited groups last month joined a lawsuit against the government over Kennedy's decision to stop recommending COVID-19 vaccines for most children and pregnant women. In a social media post Friday, one of the Kennedy-appointed ACIP members — Retsef Levi — wrote that the working groups 'will engage experts from even broader set of disciplines!' Levi, a business management professor, also wrote that working group membership 'will be based on merit & expertise — not membership in organizations proven to have (conflicts of interest) and radical & narrow view of public health!' HHS officials have not said which people are going to be added to the ACIP workgroups. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
